FDA OKs First Fast-Acting Insulin Biosimilar for Diabetes
Feb. 20, 2025 — The FDA has approved a new fast-acting insulin biosimilar to help manage blood sugar in people […]
Feb. 20, 2025 — The FDA has approved a new fast-acting insulin biosimilar to help manage blood sugar in people […]
The FDA has approved Merilog, a new fast-acting insulin biosimilar for managing blood sugar in people with diabetes, marking the first such biosimilar to receive federal approval.
Feb. 20, 2025 — The FDA has approved a new fast-acting insulin biosimilar to help manage blood sugar in people